Ambassador Kenji Hiramatsu attended and delivered the address at the opening session of “1st India-Japan Medical Products Regulation Symposium” co-organized by Ministry of Health, Labour and Welfare of Japan and Ministry of Health and Family Welfare of India on 18th May, 2016.
(Address by H.E. Mr. Kenji Hiramatsu, Ambassador of Japan to India)
Cooperative activities between Japan and India in medical products regulation has been carried out based on the Memorandum of Cooperation on Pharmaceutical Affairs Regulation Dialogue and Cooperation Framework, which was signed in December, 2015.
“1st India-Japan Medical Products Regulation Symposium” was organized by Ministry of Health, Labour and Welfare and Pharmaceutical Medical Devices Agency (PMDA) of Japan and Ministry of Health and Family Welfare and Central Drugs Standard Control Organisation (CDSCO) of India from 18th to 19th of May, 2016 at New Delhi, India. In this symposium, lectures were given from both regulators for the outlines and the latest trends of the regulations for drugs, medical devices and regenerative medical products, etc. and from industries of both countries for their activities related to the regulations. Both regulators also held a bilateral meeting and exchanged opinions.
It is expected the improvement of mutual credibility and the levels of regulations of both countries brought by these activities will raise the quality of drugs exported from India to Japan, foster appropriate regulatory circumstance in which Japanese drugs and medical devices industries do business, improve the level of public health in India and heighten the international credibility on Japanese medical products regulation.
Ambassador Kenji Hiramatsu attends “1st India-Japan Medical Products Regulation Symposium”
May 19, 2016